Evidence map›Paper›PMID 42192884›Full record

ArticleCancers2026

Prognostic Impact of Brain Radiotherapy and Lactate Dehydrogenase in Melanoma with Brain Metastases: A Retrospective Cohort Study.

Huishan Zhang, Mengru Quan, Zhongqiao Lin, Zequn Sun, Yu Chen, Jing Lin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huishan ZhangDepartment of Phase I Clinical Trial, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China.
Mengru QuanCollege of Chemistry, Fuzhou University, Fuzhou 350014, China.
Zhongqiao LinDepartment of Phase I Clinical Trial, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China.
Zequn SunCollege of Chemistry, Fuzhou University, Fuzhou 350014, China.
Yu ChenNHC Key Laboratory of Cancer Metabolism, Fujian Cancer Hospital, Fuzhou 350014, China.
Jing LinNHC Key Laboratory of Cancer Metabolism, Fujian Cancer Hospital, Fuzhou 350014, China.

Funding

Fujian Provincial Health Commission Science and Technology 2025QNA049Joint Funds for the Innovation of Science and Technology 2023Y9412Natural Science Foundation of Fujian Province 2023J011254Startup Fund for scientific research 2023QH1171the Science Foundation for The Excellent Youth Scholars of Fujian Provincial Health Commission 2022ZQNZD009
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

brain metastaseslactate dehydrogenase (LDH)melanomaoverall survivalprognosisradiotherapy

Identifiers

PMID42192884
PMCPMC13204865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.